Patents by Inventor Simon Osborne

Simon Osborne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260184687
    Abstract: The present invention relates to compounds that are MALT1 inhibitors. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with MALT1.
    Type: Application
    Filed: May 12, 2023
    Publication date: July 2, 2026
    Inventors: Ian Duncan Linney, Nicholas Charles Ray, Oliver Thomas Kern, Martin John Watson, Paul Matthew Blaney, Grzegorz K. Zielinski, Simon Osborne, Martin Ambler
  • Publication number: 20250326754
    Abstract: Provided are compounds and method for inhibiting DNA-dependent protein kinase (DNA-PK). Aspects of the present disclosure also include methods of using the compounds to treat disease, including, but not limited to, cancer. In certain embodiments, the compounds inhibit DNA-PK and thus sensitize cancers to therapies such as chemotherapy and radiotherapy. Compounds provided are of Formula (I).
    Type: Application
    Filed: May 11, 2023
    Publication date: October 23, 2025
    Inventors: Stephen Paul Arns, Tom Han Hsiao Hsieh, Fahimeh S. Shidmoossavee, Jason Samuel Tan, Leanna Yee, Jay John Paquette, Simon Osborne, Callum Hamby, Andrew I. Minchinton, Alastair H. Kyle, Jennifer H.E. Baker
  • Publication number: 20250136577
    Abstract: The present invention relates to compounds that are MALT1 inhibitors. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with MALT1.
    Type: Application
    Filed: February 3, 2023
    Publication date: May 1, 2025
    Inventors: Ian Duncan Linney, Nicholas Charles Ray, Martin John Watson, Paul Matthew Blaney, Oliver Thomas Kern, Simon Osborne, Martin Amber, Chido Mpamhanga
  • Publication number: 20240208934
    Abstract: Described herein are compounds that are ULK1/2 inhibitors and their use in the treatment of disorders such as cancers.
    Type: Application
    Filed: April 6, 2022
    Publication date: June 27, 2024
    Inventors: Martin AMBLER, Edward Giles McIVER, Chidochangu MPAMHANGA, Simon OSBORNE
  • Patent number: 10961234
    Abstract: A first aspect of the invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein: •B is an aryl or heteroaryl group optionally substituted by one or more R10 groups; and *X is selected from 0, (CR11R12)p and (CR11R12)p CO. Said compounds are capable of inhibiting PAICS and are useful in the treatment of proliferative disorders. Further aspects relate to pharmaceutical compositions, therapeutic uses and process for preparing compounds of formula (I).
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: March 30, 2021
    Assignee: LIFEARC
    Inventors: Simon Osborne, Jonathan Large
  • Patent number: 10961233
    Abstract: A first aspect of the invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, • B is a saturated or partially unsaturated monocyclic or bicyclic, heterocyclic group optionally substituted by one or more R 10 groups; *X is selected from SO2, CO2, CO, CONR11 and (CR12R13) p. Said compounds are capable of inhibiting PAICS and are useful in the treatment of proliferative disorders. Further aspects relate to pharmaceutical compositions, therapeutic uses and process for preparing compounds of formula (I).
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: March 30, 2021
    Assignee: LIFEARC
    Inventors: Simon Osborne, Jonathan Large
  • Publication number: 20190352296
    Abstract: A first aspect of the invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein: •B is an aryl or heteroaryl group optionally substituted by one or more R10 groups; and *X is selected from 0, (CR11R12)p and (CR11R12)p CO. Said compounds are capable of inhibiting PAICS and are useful in the treatment of proliferative disorders. Further aspects relate to pharmaceutical compositions, therapeutic uses and process for preparing compounds of formula (I).
    Type: Application
    Filed: December 19, 2017
    Publication date: November 21, 2019
    Inventors: Simon OSBORNE, Jonathan LARGE
  • Publication number: 20190352295
    Abstract: A first aspect of the invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, • B is a saturated or partially unsaturated monocyclic or bicyclic, heterocyclic group optionally substituted by one or more R 10 groups; * X is selected from SO2, CO2, CO, CONR11 and (CR12 R13) p. Said compounds are capable of inhibiting PAICS and are useful in the treatment of proliferative disorders. Further aspects relate to pharmaceutical compositions, therapeutic uses and process for preparing compounds of formula (I).
    Type: Application
    Filed: December 19, 2017
    Publication date: November 21, 2019
    Inventors: Simon OSBORNE, Jonathan LARGE
  • Patent number: 10264098
    Abstract: A system for assembling and delivering a communications service or product is described which is flexible to accommodate the rapid introduction of new product/service offerings on a frequent basis. The method involves receiving data relating to a number of communication service components and creating and storing a data structure for each communication service component. Data is also received relating to a communication service, the data identifying at least one of the communication service components and a data structure for the communications service is created and stored. In response to receiving an input requesting provisioning of the communications service, an end-to-end process flow for delivering the communications service is automatically created based on the data structure for the communications service and the data structure for the identified communication service components.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: April 16, 2019
    Assignee: CISCO TECHNOLOGY, INC.
    Inventors: Brian Naughton, Simon Osborne, Gareth Senior, Paul Kitteringham
  • Publication number: 20160150051
    Abstract: A system for assembling and delivering a communications service or product is described which is flexible to accommodate the rapid introduction of new product/service offerings on a frequent basis. The method involves receiving data relating to a number of communication service components and creating and storing a data structure for each communication service component. Data is also received relating to a communication service, the data identifying at least one of the communication service components and a data structure for the communications service is created and stored. In response to receiving an input requesting provisioning of the communications service, an end-to-end process flow for delivering the communications service is automatically created based on the data structure for the communications service and the data structure for the identified communication service components.
    Type: Application
    Filed: January 28, 2016
    Publication date: May 26, 2016
    Inventors: Brian Naughton, Simon Osborne, Gareth Senior, Paul Kitteringham
  • Patent number: 9258370
    Abstract: A system for assembling and delivering a communications service or product is described which is flexible to accommodate the rapid introduction of new product/service offerings on a frequent basis. The method involves receiving data relating to a number of communication service components and creating and storing a data structure for each communication service component. Data component is also received relating to a communication service, the data identifying at least one of the communication service components and a data structure for the communications service is created and stored. In response to receiving an input requesting provisioning of the communications service, an end-to-end process flow for delivering the communications service is automatically created based on the data structure for the communications service and the data structure for the identified communication service components.
    Type: Grant
    Filed: November 26, 2007
    Date of Patent: February 9, 2016
    Assignee: Cisco Technology, Inc.
    Inventors: Brian Naughton, Simon Osborne, Gareth Senior, Paul Kitteringham
  • Publication number: 20100005174
    Abstract: A system for assembling and delivering a communications service or product is described which is flexible to accommodate the rapid introduction of new product/service offerings on a frequent basis. The method involves receiving data relating to a number of communication service components and creating and storing a data structure for each communication service component. Data component is also received relating to a communication service, the data identifying at least one of the communication service components and a data structure for the communications service is created and stored. In response to receiving an input requesting provisioning of the communications service, an end-to-end process flow for delivering the communications service is automatically created based on the data structure for the communications service and the data structure for the identified communication service components.
    Type: Application
    Filed: November 26, 2007
    Publication date: January 7, 2010
    Applicant: AXIOM SYSTEMS LIMITED
    Inventors: Brian Naughton, Simon Osborne, Gareth Senior, Paul Kitteringham
  • Patent number: 6133307
    Abstract: The novel compounds of formula (I) of the instant invention are selective kappa opioid agonists useful in the treatment of arthritis, hypertension, pain, inflammation, migraine, inflammatory disorders of the gastrointestinal tract, IBS, and psoriasis. The compounds, novel intermediates useful in their preparations and pharmaceutical compositions containing them, are part of the invention.
    Type: Grant
    Filed: June 30, 1999
    Date of Patent: October 17, 2000
    Assignee: Warner-Lambert Company
    Inventors: David Christopher Horwell, Simon Osborne
  • Patent number: 6057357
    Abstract: The compounds of the instant invention as those of Formula I ##STR1## or a pharmaceutically acceptable salt thereof are peripherally selective kappa opioid agonists that are useful in treating pain, inflammation, psoriasis and irritable bowel syndrome.
    Type: Grant
    Filed: June 24, 1999
    Date of Patent: May 2, 2000
    Assignee: Warner-Lambert Company
    Inventors: David Christopher Horwell, Simon Osborne
  • Patent number: 5554644
    Abstract: The compounds of the instant invention are ligands for the NK.sub.2 receptor. The compounds are modified at the C-terminus to provide various amide isostere derivatives expected to be useful in treating obesity, anxiety, gastrointestinal ulcers, pain, stroke, and inflammation. Pharmaceutical compositions and methods of using the compounds are also included.
    Type: Grant
    Filed: June 8, 1994
    Date of Patent: September 10, 1996
    Assignee: Warner-Lambert Company
    Inventors: David C. Horwell, William Howson, Simon Osborne